ES2173198T3 - Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda. - Google Patents

Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.

Info

Publication number
ES2173198T3
ES2173198T3 ES95933902T ES95933902T ES2173198T3 ES 2173198 T3 ES2173198 T3 ES 2173198T3 ES 95933902 T ES95933902 T ES 95933902T ES 95933902 T ES95933902 T ES 95933902T ES 2173198 T3 ES2173198 T3 ES 2173198T3
Authority
ES
Spain
Prior art keywords
propenoic acid
derivatives
heterocicles
nmda antagonists
acid replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933902T
Other languages
English (en)
Inventor
Boyd L Harrison
Philip L Nyce
Robert A Farr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2173198T3 publication Critical patent/ES2173198T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBEN DERIVADOS DE ACIDO PROPENOICO, SUSTITUIDOS EN POSICION 3 CON UN HETEROCICLO, DE FORMULA (I), DONDE G ES UN RADICAL ELEGIDO ENTRE EL GRUPO (A), (B) O (C). DICHOS DERIVADOS DE ACIDO PROPENOICO, SON UTILES COMO ANTAGONISTAS DE NMDA.
ES95933902T 1994-10-31 1995-09-21 Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda. Expired - Lifetime ES2173198T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
ES2173198T3 true ES2173198T3 (es) 2002-10-16

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933902T Expired - Lifetime ES2173198T3 (es) 1994-10-31 1995-09-21 Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.

Country Status (21)

Country Link
US (3) US5563157B1 (es)
EP (1) EP0790994B1 (es)
JP (1) JP3934678B2 (es)
KR (1) KR100401138B1 (es)
CN (1) CN1068001C (es)
AT (1) ATE217307T1 (es)
AU (1) AU696423B2 (es)
CA (1) CA2202992C (es)
DE (1) DE69526668T2 (es)
DK (1) DK0790994T3 (es)
ES (1) ES2173198T3 (es)
FI (1) FI971831A0 (es)
HU (1) HU222372B1 (es)
IL (1) IL115791A (es)
MX (1) MX9703146A (es)
NO (1) NO313197B1 (es)
NZ (1) NZ293842A (es)
PT (1) PT790994E (es)
TW (1) TW336232B (es)
WO (1) WO1996013501A1 (es)
ZA (1) ZA959046B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
CA2427499A1 (en) 2000-10-10 2002-04-18 Smithkline Beecham Corporation Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー　ユニバーシティ ｐＨに依存するＮＭＤＡレセプターアンタゴニスト
NZ582917A (en) * 2007-06-29 2013-01-25 Univ Emory Nmda receptor antagonists for neuroprotection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0539503B1 (en) * 1990-07-16 1996-04-03 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
PT99207B (pt) * 1990-10-15 1999-04-30 Astra Ab Processo de preparacao de derivados da piperidina e de composicoes farmaceuticas
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
DK0701551T3 (da) * 1993-05-27 1997-10-20 Merrell Pharma Inc 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister

Also Published As

Publication number Publication date
EP0790994B1 (en) 2002-05-08
AU696423B2 (en) 1998-09-10
FI971831A (fi) 1997-04-29
TW336232B (en) 1998-07-11
KR100401138B1 (ko) 2003-12-24
JP3934678B2 (ja) 2007-06-20
US5981553A (en) 1999-11-09
NO971991D0 (no) 1997-04-29
HUT77174A (hu) 1998-03-02
CN1068001C (zh) 2001-07-04
IL115791A (en) 2000-09-28
CA2202992C (en) 2003-05-13
IL115791A0 (en) 1996-01-19
AU3638795A (en) 1996-05-23
EP0790994A1 (en) 1997-08-27
ATE217307T1 (de) 2002-05-15
NO313197B1 (no) 2002-08-26
MX9703146A (es) 1997-06-28
NO971991L (no) 1997-04-29
US5563157A (en) 1996-10-08
JPH10508019A (ja) 1998-08-04
DE69526668D1 (de) 2002-06-13
DE69526668T2 (de) 2003-01-02
WO1996013501A1 (en) 1996-05-09
US6180786B1 (en) 2001-01-30
FI971831A0 (fi) 1997-04-29
PT790994E (pt) 2002-08-30
CN1161696A (zh) 1997-10-08
NZ293842A (en) 1998-09-24
HU222372B1 (hu) 2003-06-28
DK0790994T3 (da) 2002-08-26
ZA959046B (en) 1996-05-17
CA2202992A1 (en) 1996-05-09
US5563157B1 (en) 1999-02-02

Similar Documents

Publication Publication Date Title
PT891325E (pt) Derivados do acido fenilpropanoico para-substituido como antagonistas de integrina
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
ES2179318T3 (es) Derivados de acido cinamico y su uso como antagonistas de integrina.
PT863875E (pt) Novos compostos 4-(oxialcoxifenil)-3-oxi-piperidina para o tratamento de insuficiencia cardiaca e renal
ATE233274T1 (de) Oxyiminopregnancarbolactone
DE69616480T2 (de) Piperidinderivate als neurokininantagonisten
DE69926806D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
MX9702070A (es) Nuevos inhibidores de resorcion osea y antagonistas de receptor de vitronectina.
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
MY106964A (en) Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
ES2159717T3 (es) Derivados de acido 5-(piperidinil-1 sustituido en posicion 4)-3-aril-pentanoico como antagonistas de los receptores de taquiquinina.
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
ES2173198T3 (es) Derivados de acido propenoico sustituidos con heterociclos, como antagonistas de nmda.
ATE375985T1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
ATE279923T1 (de) Urotensin-ii rezeptorantagonisten
EA200400822A1 (ru) Производные 3,4-дигидро-1h-изохинолин-2-ила
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.
DE69526738T2 (de) Endothelin-rezeptor-antagonisten
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE60006125D1 (de) Herstellung von 2-(2-arylmorpholin-2-yl)ethanolderivaten und zwischenprodukte
TR200103475T2 (tr) Aril ikameli nitrogen heterosaykıllı yeni karboksilik asit türevleri
IT1274022B (it) Derivati della cumarina ad attivita' farmacologica, loro uso e composizioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 790994

Country of ref document: ES